MedPath

Turmeric in the treatment of recurrent aphthous stomatitis

Phase 2
Conditions
Recurrent aphthous stomatitis.
Recurrent oral aphthae
K 12.0
Registration Number
IRCT201107311556N28
Lead Sponsor
Erphan Teb
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
50
Inclusion Criteria

50 Patients between 20 and 45 years old will be included if they present with 1–5 aphthous ulcers of less than 24 h duration. The ulcers diameter will not be greater than 6 mm and they do not suffer from acute or chronic diseases of the oral mucosa Patients will be excluded from the study if they have concurrent clinical conditions including serious liver, kidney, and heart dysfunctions or if they have ulcers as a manifestation of a systemic disease process such as ulcerative colitis, Crohn’s disease, Behcet’s syndrome, or serious anaemia. To minimize the effect of confounding variables in the psycho- physiological component of the study, the patients should not have a history of alcohol or drug abuse and should not take any narcotic analgesics. Patients will be excluded if they have a history of systemic immunosuppressive therapy.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrease of pain. Timepoint: Before treatment and days 2, 4, 6, 10 and 14 after treatment. Method of measurement: VAS rating scale.
Secondary Outcome Measures
NameTimeMethod
Size of ulcers. Timepoint: Before drug application (day 0) and at days 2, 6, 10 and 14. Method of measurement: Diameters.
© Copyright 2025. All Rights Reserved by MedPath